Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.

Author: AabergThomas M, GrossniklausHans E, HubbardG Baker, KangShin J, SchmackIngo

Paper Details 
Original Abstract of the Article :
PURPOSE: To report four cases of optic nerve neuropathy in three children treated with periocular carboplatin injections for unilateral or bilateral intraocular retinoblastoma. DESIGN: Retrospective, observational case series. SETTING: University-based Ophthalmology Practice. STUDY POPULATION: Fo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ajo.2006.02.044

データ提供:米国国立医学図書館(NLM)

A Warning in the Desert of Retinoblastoma Treatment

Retinoblastoma, a cancer of the eye, can be a challenging condition to treat. This research explores the use of periocular carboplatin injections as a potential treatment option for retinoblastoma. While this approach can be effective, it comes with a potential risk that must be carefully considered, like a hidden mirage in a seemingly safe desert oasis.

A Potential Side Effect: Ischemic Optic Neuropathy

This study reports four cases of optic nerve neuropathy in children who received periocular carboplatin injections for retinoblastoma. While carboplatin can be a valuable tool in the fight against retinoblastoma, this research highlights the importance of being aware of its potential side effects. This knowledge is essential for making informed treatment decisions and ensuring the safety of young patients.

Navigating the Desert of Retinoblastoma Treatment

This study underscores the need for careful consideration of treatment options for retinoblastoma. While periocular carboplatin injections can be effective, the risk of ischemic optic neuropathy must be weighed against its potential benefits. Further research is needed to optimize this approach and minimize the risk of complications.

Dr.Camel's Conclusion

This research serves as a reminder that the desert of cancer treatment can be filled with unexpected dangers, even when using seemingly safe and effective treatments. It's important to be aware of potential side effects and to carefully weigh the risks and benefits of each treatment option.

Date :
  1. Date Completed 2006-08-29
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

16876514

DOI: Digital Object Identifier

10.1016/j.ajo.2006.02.044

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.